EssilorLuxottica buys Signifeye and announces research tie-up
Global eyewear giant EssilorLuxottica has reached agreement to acquire Signifeye, a privately held ophthalmology platform running 15 eye centres and clinics across the Flanders region of Belgium. Announced on Friday, December 12, the deal lands just months after the group’s purchase of Optegra, a 70-site network spanning five European countries, and signals continued momentum in building a pan-European clinical footprint. Management…
EssilorLuxottica unveils challenge to invasive myopia treatment
EssilorLuxottica’s unveiling of Stellest 2.0 spectacle lenses at China’s International Import Expo on November 5 points to a data-driven, non-invasive alternative to atropine drops or refractive surgery, potentially redirecting paediatric eye-care pathways. Med-tech players should note the lens-plus-sensor model, which marries diagnostics, compliance analytics, and hardware – is an architecture transferrable to other chronic-care settings. EssilorLuxottica is a global leader in…
Post-closing implications as EssilorLuxottica closes Optegra acquisition
EssilorLuxottica has closed the purchase of Optegra, a 70-clinic ophthalmology network spanning the UK, Czech Republic, Poland, Slovakia and the Netherlands. The transaction vaults the group from a dominant eyewear manufacturer-retailer into a vertically integrated eye-health services platform capable of owning the entire patient journey—from screening and diagnosis to surgery, prescription, and connected eyewear. How will this reshape the global…